JPS4962618A - - Google Patents

Info

Publication number
JPS4962618A
JPS4962618A JP48096796A JP9679673A JPS4962618A JP S4962618 A JPS4962618 A JP S4962618A JP 48096796 A JP48096796 A JP 48096796A JP 9679673 A JP9679673 A JP 9679673A JP S4962618 A JPS4962618 A JP S4962618A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP48096796A
Other languages
Japanese (ja)
Other versions
JPS535371B2 (enrdf_load_html_response
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00285036A external-priority patent/US3823228A/en
Application filed filed Critical
Publication of JPS4962618A publication Critical patent/JPS4962618A/ja
Publication of JPS535371B2 publication Critical patent/JPS535371B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A61K39/225—Porcine transmissible gastroenteritis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
JP9679673A 1972-08-30 1973-08-30 Expired JPS535371B2 (enrdf_load_html_response)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00285036A US3823228A (en) 1971-09-29 1972-08-30 Tge virus vaccine

Publications (2)

Publication Number Publication Date
JPS4962618A true JPS4962618A (enrdf_load_html_response) 1974-06-18
JPS535371B2 JPS535371B2 (enrdf_load_html_response) 1978-02-27

Family

ID=23092469

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9679673A Expired JPS535371B2 (enrdf_load_html_response) 1972-08-30 1973-08-30

Country Status (9)

Country Link
JP (1) JPS535371B2 (enrdf_load_html_response)
AR (1) AR197158A1 (enrdf_load_html_response)
AU (1) AU5949773A (enrdf_load_html_response)
CA (1) CA1023266A (enrdf_load_html_response)
DE (1) DE2343570A1 (enrdf_load_html_response)
FR (1) FR2197576B1 (enrdf_load_html_response)
GB (1) GB1440214A (enrdf_load_html_response)
NL (1) NL7312032A (enrdf_load_html_response)
PH (1) PH10296A (enrdf_load_html_response)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5892610A (ja) * 1981-11-20 1983-06-02 ベンツォン　ファーマ　エイ／エス 経口用放出調整複合単位製剤

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009577A1 (en) * 1978-08-18 1980-04-16 Burns-Biotec Laboratories Inc. An oral vaccine preparation and a method for increasing the resistance of swine to swine-dysentery infection
US5811128A (en) * 1986-10-24 1998-09-22 Southern Research Institute Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
DE19741114C2 (de) * 1997-09-12 2002-10-24 Riemser Arzneimittel Ag Feuchtigkeitsstabile und magensaftresistente Arzneiform für Fische

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458621A (en) * 1966-08-31 1969-07-29 American Home Prod Tablet dosage-form for the immunization of the intestinal tract with live virus preparations
US3519710A (en) * 1967-08-10 1970-07-07 Edmund P Bass Direct active modified live virus vaccine immunization against transmissible gastroenteritis in swine piglets at birth

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5892610A (ja) * 1981-11-20 1983-06-02 ベンツォン　ファーマ　エイ／エス 経口用放出調整複合単位製剤

Also Published As

Publication number Publication date
FR2197576A1 (enrdf_load_html_response) 1974-03-29
NL7312032A (nl) 1975-03-04
AR197158A1 (es) 1974-03-15
JPS535371B2 (enrdf_load_html_response) 1978-02-27
DE2343570A1 (de) 1974-03-14
GB1440214A (en) 1976-06-23
AU5949773A (en) 1975-02-27
FR2197576B1 (enrdf_load_html_response) 1976-09-03
CA1023266A (en) 1977-12-27
PH10296A (en) 1976-11-10

Similar Documents

Publication Publication Date Title
FR2191114A1 (enrdf_load_html_response)
BE818704A (fr) Perfectionnements aux procedes et dispositifs pour elaborer desmateriaux ameliores en feuille a partir d'une matiere thermoplastique
CH566523A5 (enrdf_load_html_response)
CH568726A5 (enrdf_load_html_response)
BG18384A1 (enrdf_load_html_response)
BG18568A1 (enrdf_load_html_response)
BG18980A1 (enrdf_load_html_response)
BG21732A1 (enrdf_load_html_response)
CH1244273A4 (enrdf_load_html_response)
CH1411973A4 (enrdf_load_html_response)
CH1413073A4 (enrdf_load_html_response)
CH566666A5 (enrdf_load_html_response)
CH566664A5 (enrdf_load_html_response)
CH559214A5 (enrdf_load_html_response)
CH559623A5 (enrdf_load_html_response)
CH559647A5 (enrdf_load_html_response)
CH560133A5 (enrdf_load_html_response)
CH561361A5 (enrdf_load_html_response)
CH562659A5 (enrdf_load_html_response)
CH563174A5 (enrdf_load_html_response)
CH563555A5 (enrdf_load_html_response)
CH565177A5 (enrdf_load_html_response)
CH565347A5 (enrdf_load_html_response)
CH566361A5 (enrdf_load_html_response)
BG18373A1 (enrdf_load_html_response)